The CAVIAR trial evaluated safety and efficacy of the PCSK9 inhibitor alirocumab for prevention of cardiac allograft vasculopathy after heart transplantation. Once-weekly subcutaneous semaglutide 2.4 ...

Background: Little is known about the comparative risks and timing of patient-defined adverse cardiovascular and noncardiovascular events (PACE) after coronary artery revascularization. We ...

Abstract: I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, ...

The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...

Cardiology is a medical specialty that is concerned with the structure and function of the heart and vasculature, and the diagnosis and treatment of patients with cardiovascular diseases.

Appendix 1. Author Relationships with Industry and Other Entities (Relevant) e115 Appendix 2. Reviewer Relationships with Industry and Other Entities (Comprehensive) e117 When developing ...

Because outcomes for patients with aortic disease are enhanced at programs with higher volumes, experienced practitioners, and extensive management capabilities, Multidisciplinary Aortic Team care is ...

Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in ...

† Wallace H. Coulter Department of Biomedical Engineering at Emory University and Georgia Institute of Technology, 1760 Haygood Drive, W200, Atlanta, Georgia 30322, United States ‡ George W. Woodruff ...

† Department of Pharmaceutics and Pharmaceutical Chemistry, Health Sciences, University of Utah, Salt Lake City, Utah 84112, United States ‡ Program in Molecular Medicine, University of Utah School of ...